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Contraceptive Hormone Use and Cardiovascular Disease
Since their introduction in the 1960s, oral contraceptives (OCs) have been used byapproximately 80% of U.S. women at some point in their lives. The Women’s
Health Initiative demonstrated increased cardiovascular risk with menopausal hor-
mone therapy, prompting review of the safety, efficacy, and side effects of other forms
of hormone therapy. This review by Shufelt and Bairey Merz outlines the physiology
and mechanisms of cardiovascular action of contraceptive hormones, particularly those
found in OCs. It includes basic science, animal, and human clinical studies that address
contraceptive hormone use and cardiovascular disease. The current guidelines for
contraceptive hormone use in women with elevated cardiovascular risk are also re-
viewed. See page 221.
Page 237
Interventional Cardiology
Clinical Experience With a Combined CABG/PCI Suite
Routine angiography immediately after coronary artery bypass grafting (CABG),prior to chest closure, may help to identify graft anomalies that will increase the
risk of failure and allow surgical revision or percutaneous revascularization. Zhao and
colleagues describe their experiences with routine completion angiography in almost
400 patients who underwent CABG, some of whom had simultaneous (“1-stop”)
percutaneous coronary intervention (PCI) in a hybrid catheterization laboratory/
operating room. Nearly one-third had a combined procedure; 60% of these were
planned and 40% were ad hoc based on intraoperative findings. Twelve percent of
grafts were found to have angiographic defects that were repaired with a minor
adjustment of the graft, intraoperative open-chest PCI, or traditional surgical revision.
Hybrid patients had clinical outcomes similar to standard CABG patients. Routine
completion angiography may help to identify grafts with suboptimal results and allow
appropriate corrections prior to CABG completion. See pages 232 and 242.
See figure.
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Coronary Disease
Lipid Profiles of Asians With First MI
Most of the information regarding the contributions of various lipid fractions tocardiovascular disease risk is derived from studies in white Caucasians, but
might vary between ethnic groups due to either genetic or environmental factors such
as high carbohydrate diets, reduced physical activity, smoking rates, and so on. The
INTERHEART study is an international study of subjects with a first acute myocardial
infarction (AMI) compared with control patients, with 65 centers in Asia and almost
6,000 Asian patients with AMI. Among both cases and control subjects, mean low-
density lipoprotein cholesterol (LDL-C) levels were about 10 mg/dl lower in Asians
compared with non-Asians. Asian cases and control subjects were more likely to have
LDL-C 100 mg/dl. Despite these differences in absolute levels, the risk of AMI
associated with increases in LDL-C and decreases in high-density lipoprotein choles-
terol was similar for Asians and non-Asians. Because Asians are at risk for AMI despite
lower LDL-C levels, the treatment threshold and targets may need to be reassessed in
this population. See page 244. See figure.
Page 260
Heart Failure
A Call to Assess All AHFS Patients for CAD
Patients with acute heart failure syndromes (AHFS) are heterogeneous in terms oftheir clinical presentation, pathophysiology, prognosis, and therapeutic options.
The majority of patients presenting with AHFS have coronary artery disease (CAD),
which can be either stable or unstable, but the role of CAD in AHFS has not been
well-studied in clinical trials. This paper represents a consensus summary of discussions
that occurred during the Fourth International Acute Heart Failure Syndromes Work-
ing Group meeting. Currently, there are no consensus statements or practice guidelines
on the most appropriate timing and methods to detect or reassess CAD in patients with
AHFS, but several lines of evidence suggest that CAD can significantly affect outcomes
for AHFS patients, but it is most likely underdiagnosed during the index hospitaliza-
tion. See page 254. See figure.
Heart Failure
VADs May Increase Post-Transplant Mortality
Ventricular assist devices (VADs) have been shown to improve end organ perfusionand are increasingly being used to bridge patients to heart transplantation, but the
effect of these devices on post-transplant mortality is unclear. Patlolla and colleagues
reviewed data from the United Network for Organ Sharing (UNOS) Thoracic Regis-
try for over 10,000 patients who underwent a single-organ heart transplantation. One
thousand four hundred thirty-three patients were bridged with intracorporeal VADs
and 448 patients with extracorporeal VADs. Intracorporeal VADs were associated with
a hazard ratio (HR) of 1.2 for 6-month post-transplant mortality and an HR of 2.0
beyond 5 years. The HRs for extracorporeal VADs were 1.9 and 2.9, respectively.
These data suggest that VADs increase both short- and long-term mortality and argue
against using these devices as bridges in stable UNOS status I patients awaiting heart
transplantation. See pages 264 and 272.(continued on page A-22)
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Heart Rhythm Disorders
Predictors of Arrhythmias in Asymptomatic Children With Pre-Excitation
Patients with ventricular pre-excitation (Wolff-Parkinson-White [WPW] syn-drome) on the electrocardiogram (ECG) are at a small but real risk of sudden
death, but the predictors of which patients are at highest risk are poorly understood.
Santinelli and colleagues performed electrophysiologic testing and prospectively fol-
lowed more than 200 children (ages 5 to 18 years) who were found to have WPW
syndrome on a screening ECG and were asymptomatic. More than 70% of the
children had no arrhythmic events over a median follow-up of almost 5 years. Thirty
percent did develop a first arrhythmic event, which was potentially life-threatening in
approximately 10% of all children screened, or40% of children with arrhythmias.
Tachyarrhythmia inducibility, short anterograde refractory period of accessory path-
ways (APs), and presence of multiple pathways were predictors of potentially life-
threatening arrhythmias. These findings will help to identify high-risk asymptomatic
children with ventricular pre-excitation who may be candidates for AP ablation.
See pages 275 and 281. See figure.
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Cardiac Imaging
Cardiac Fibrosis Common in Patients With LVH
The relationship between left ventricular hypertrophy (LVH) and myocardialfibrosis as defined by late gadolinium enhancement (LGE) cardiovascular mag-
netic resonance (CMR) is not well understood. Rudolph and colleagues evaluated the
incidence and patterns of LGE in different forms of LVH. Over 400 patients with
aortic stenosis, arterial hypertension, or hypertrophic cardiomyopathy with echocar-
diographic criteria of LVH underwent CMR. LGE was present in all forms of LVH
and correlated with LV mass index. There were no significant differences in the
frequency of LGE. Fibrosis as detected by CMR is a frequent feature of LVH
regardless of its cause and depends on the severity of the increase in the LV mass
index. See pages 284 and 292. See figure.
